Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are willing to give informed written consent,ASA I-II patients,patients with BMI less than 30 kg/m2,patients undergoing Elective Surgery under General Anesthesia
Exclusion criteria
Exclusion criteria: Allergic to any study Drugs,Patients with severe systemic disease,Pregnant or Lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time gap between the loss of visual fade to return of TOF Ratio more than or equal to 0.9 after administration of Neostigmine or Sugammadex at two visible twitches during Train-of-Four monitoringTimepoint: Time from administration of reversal to TOF Ratio 0.70,0.80,0.90 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Duration of Surgery 2.Administration & Dosage of Neuromuscular Blocking Agents 3.Heart Rate,Systolic Blood Pressure,Diastolic Blood Pressure,Mean Arterial Pressure 4.Post Operative Residual Neuromuscular Block Associated Adverse eventsTimepoint: Before administration of reversal agents,1 minute,5 minutes & 10 minutes after administration of reversal agents | — |
Countries
India
Contacts
Department of Anaesthesiology and Critical Care,Tezpur Medical College and Hospital,Tezpur